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Abstract
White-nose syndrome (WNS) is a fungal disease caused by Pseudogymnoascus
destructans (Pd) that affects bats during hibernation. Although millions of bats
have died from WNS in North America, mass mortality has not been observed
among European bats infected by the fungus, leading to the suggestion that bats
in Europe are immune. We tested the hypothesis that an antibody-mediated
immune response can provide protection against WNS by quantifying antibod-
ies reactive to Pd in blood samples from seven species of free-ranging bats in
North America and two free-ranging species in Europe. We also quantified
antibodies in blood samples from little brown myotis (Myotis lucifugus) that
were part of a captive colony that we injected with live Pd spores mixed with
adjuvant, as well as individuals surviving a captive Pd infection trial. Seropreva-
lence of antibodies against Pd, as well as antibody titers, was greater among lit-
tle brown myotis than among four other species of cave-hibernating bats in
North America, including species with markedly lower WNS mortality rates.
Among little brown myotis, the greatest titers occurred in populations occupy-
ing regions with longer histories of WNS, where bats lacked secondary symp-
toms of WNS. We detected antibodies cross-reactive with Pd among little
brown myotis na€ıve to the fungus. We observed high titers among captive little
brown myotis injected with Pd. We did not detect antibodies against Pd in Pd-
infected European bats during winter, and titers during the active season were
lower than among little brown myotis. These results show that antibody-medi-
ated immunity cannot explain survival of European bats infected with Pd and
that little brown myotis respond differently to Pd than species with higher
WNS survival rates. Although it appears that some species of bats in North
America may be developing resistance to WNS, an antibody-mediated immune
response does not provide an explanation for these remnant populations.
Introduction
White-nose syndrome (WNS) is a fungal disease responsi-
ble for precipitous declines in bat populations in North
America (Lorch et al. 2011; Blehert 2012; Reeder and
Moore 2013; Frick et al. 2015). Since its discovery in New
York in 2006, millions of bats have died from WNS, with
mortality continuing at an alarming rate as the disease
spreads across the United States and Canada (Coleman
and Reichard 2014; Frick et al. 2015). Population declines
in excess of 90% have been estimated for several species,
leading to predictions of regional and species-level extinc-
tions in the near future (Frick et al. 2010, 2015; Turner
et al. 2011).
WNS is caused by the psychrophilic fungus Pseudo-
gymnoascus destructans (Pd), originally classified as
Geomyces destructans in 2009 (Gargas et al. 2009; Minnis
and Lindner 2013). Suitable temperatures for Pd growth
overlap with temperatures inside bat hibernacula (Webb
et al. 1996; Humphries et al. 2002; Verant et al. 2012),
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allowing the fungus to grow in the winter habitat of many
bat species. Pd invades the dermis and epidermis of bats
while they hibernate (Blehert et al. 2009), and infection is
likely facilitated by the reduction in immune function
typical of hibernation (Bouma et al. 2010a). Fungal
colonization causes fatal disruptions in behavior (Brown-
lee-Bouboulis and Reeder 2013; Wilcox et al. 2014) and
physiology (Verant et al. 2014), including energy and
water balance (Cryan et al. 2010, 2013). The critical dis-
ruption in energy balance is illustrated by the hibernation
ecology of little brown myotis (Myotis lucifugus) that,
when affected by WNS, exhibit an increase in frequency
of arousals from hibernation, depleting fat reserves neces-
sary to survive winter (Reeder et al. 2012; Warnecke et al.
2012). Little brown myotis suffering from WNS are also
more dehydrated than healthy bats, suggesting evaporative
water loss could at least partially explain this increase in
arousals (Cryan et al. 2013).
Pd is not native to North America; it is believed to
have been introduced from Europe, where it is wide-
spread (Puechmaille et al. 2011; Warnecke et al. 2012;
Wibbelt et al. 2013). European isolates of Pd cause mor-
tality in North American bats (Warnecke et al. 2012), but
European bats infected with Pd do not appear to have the
same pathology (Wibbelt et al. 2013). The discovery of
Pd growing on European bats during hibernation led to
the suggestion that European bats may be immune to
WNS (Puechmaille et al. 2010). However, some mammal
immune responses have been shown to be suppressed
during hibernation (Bouma et al. 2010a). Hibernating
bats, therefore, likely have a limited ability to mount an
immune response to Pd during the period of active infec-
tion. The reduction of immune function during hiberna-
tion should not be interpreted to mean that a protective
immune response is not possible, however, as both cell-
and antibody-mediated (humoral) immune responses can
occur during hibernation (Maniero 2002; Bouma et al.
2013). While antibody-mediated immune responses to
fungi can help clear infections, they can also lead to toler-
ance of chronic infection (Casadevall and Pirofski 2012a,
b; W€uthrich et al. 2012). Thus, the alternative hypothesis
that activation of an immune response during winter con-
tributes to pathology and mortality among North Ameri-
can species must also be considered.
The capacity to mount an immune response to Pd may
differ among bat species. For example, the little brown
myotis is a small bat (6–14 g) that exhibits relatively long
periods of torpor between periodic arousals from hiberna-
tion compared to larger species such as the big brown bat
(Eptesicus fuscus) (Brack and Twente 1985; Twente et al.
1985; Reeder et al. 2012). This greater frequency of arous-
als in big brown bats may result in greater immune com-
petence and ability to respond to Pd during winter,
possibly explaining the lower WNS mortality rates
reported for big brown bats (Turner et al. 2011; Frank
et al. 2014).
The purpose of our study was to examine the role of
antibody-mediated immune responses to Pd in captive
and free-ranging bats. We hypothesized that captive little
brown myotis exposed to Pd during hibernation would
have greater antibody titers in the spring than bats not
exposed to the pathogen. A secondary goal of our captive
study was to determine whether seroprevalence and titers
could be experimentally increased by injecting captive lit-
tle brown myotis with live Pd. Among free-ranging bats,
our goals were to determine whether free-ranging bats in
North America and Europe produce antibodies against
Pd, when antibody levels peak, and whether antibody pro-
duction varies among species and geographic regions. We
also tested whether antibody seroprevalence, defined as a
blood sample with detectable antibodies reactive to Pd,
and titer are correlates of WNS survival. We hypothesized
that European species would exhibit greater seropreva-
lence and titers than any North American species. Within
North America, we hypothesized that populations inhab-
iting regions with longer histories of WNS would exhibit
the greatest seroprevalence and titers, and that titers
would peak shortly after the end of hibernation. Finally,
we hypothesized that North American species with higher
WNS survival rates and winter ecologies favoring more
frequent arousals from hibernation would exhibit the
greatest seroprevalence and titers.
Materials and Methods
This study was carried out on bats from nonendangered
species in strict accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health. All methods were
approved by the Institutional Animal Care and Use Com-
mittee at Bucknell University (protocol DMR-016), the
Animal Ethics Committee of the University of Turku
(license number ESAVI/3221/04.10.07/2013), and the
Leibniz Institute for Zoo and Wildlife Research Berlin.
Captive studies
We established a captive population of little brown myo-
tis na€ıve to Pd in 2013. We captured bats in mist-nets
(Avinet, Inc., Dryden, NY) placed outside known WNS-
free roosts in Montana, USA, and transported to our lab-
oratory at Bucknell University in Pennsylvania, USA. Fol-
lowing arrival, 26 bats were randomly selected for an
immunization trial to determine whether anti-Pd anti-
body titers could be boosted through injection of Pd
preparations. Ten of these bats were given intraperitoneal
2 ª 2015 The Authors. Ecology and Evolution published by John Wiley & Sons Ltd.
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injections of 6 9 106 live Pd cells suspended in 0.1 mL of
phosphate buffered saline (PBS) emulsified in 0.1 mL of
the Novartis adjuvant MF59, which has been successfully
used in generating protective antifungal immunity in mice
(Torosantucci et al. 2005). As a control, 16 bats that were
housed separately were given intraperitoneal injections
containing only 0.2 mL PBS. Bats were given intraperito-
neal booster injections of either 0.2 mL PBS (control
bats) or 6 9 106 live Pd cells suspended in 0.2 mL of
PBS (immunized bats) at 1 and 3 weeks following initial
injections. We collected plasma samples from all 26 bats
6 weeks following initial injections. We collected blood
into heparinized glass microhematocrit capillary tubes
(Kimball Chase Life Science, Vineland, NJ) after punctur-
ing a vein in the uropatagium using a 27.5-gauge sterile
needle (Reeder and Widmaier 2009). Capillary tubes were
immediately centrifuged to separate plasma from blood
cells, and plasma was stored at 80°C.
For a separate captive infection experiment, we col-
lected 147 little brown myotis na€ıve to Pd from WNS-free
hibernacula in Michigan and Illinois in November of
2012 and brought them back to our laboratory (Johnson
et al. 2014). Bats were either cutaneously inoculated with
Pd (n = 118) or sham inoculated (n = 29) with PBS, and
hibernated for 5 months in captivity. Pd-inoculated bats
were hibernated in a separate chamber from control bats,
and the two groups were housed separately upon arousal
from hibernation. Pd used for inoculations was obtained
from an isolate harvested from a little brown myotis in
Pennsylvania in 2010. In order to determine whether or
not surviving WNS results in the generation of antibodies
against Pd, we collected nonterminal blood samples from
63 surviving bats (control: n = 19; Pd inoculated: n = 44)
at 2, 6, and 10 weeks following the end of hibernation.
Blood was collected and stored as described above.
Field studies
We captured bats at night using mist-nets, or captured
roosting bats by hand during the day in order to collect
nonterminal blood samples for our analysis. We collected
blood as described above, except that plasma was stored
on dry ice until transferred to our laboratory, where it
was stored at 80°C. Blood was only collected from adult
bats. In addition to collecting blood, we scored the wings
for damage considered to be a secondary symptom of
WNS (Reichard and Kunz 2009) and swabbed the wings
and muzzles to later determine the number of Pd cells
present (Johnson et al. 2014).
We collected blood from free-ranging little brown myo-
tis, northern myotis (M. septentrionalis), big brown bats,
tri-colored bats (Perimyotis subflavus), Rafinesque’s
big-eared bats (Corynorhinus rafinesquii), evening bats
(Nycticeius humeralis), and eastern red bats (Lasiurus
borealis) captured at Mammoth Cave National Park, Ken-
tucky, USA (see Table S1). Eastern red bats were the only
species in our study not known to hibernate in caves.
Samples were collected from late May through early June
(spring) of 2013 and 2014, and during late July (summer)
of 2013. Samples were also collected from little brown
myotis during the spring in New York, Pennsylvania, and
Montana (see Table S1). We also collected samples from
Daubenton’s myotis (M. daubentonii) in southwestern
Finland during the spring and summer of 2013. Bats in
Finland did not show any sign of wing damage typical of
WNS survivors in North America (Meteyer et al. 2009;
Reichard and Kunz 2009).
We collected terminal blood samples from little brown
myotis and tri-colored bats collected from two WNS-
positive caves in Kentucky, USA, in March (winter) 2014.
These bats were selected for sampling based upon the
presence of visible fungus. We swabbed the muzzles and
wings of bats to confirm the presence of Pd by qPCR
(Johnson et al. 2014). Bats were aroused for ≥1 h before
being euthanized using isoflurane followed by decapita-
tion. We also collected terminal winter samples from a
European species, greater mouse-eared myotis (M. myo-
tis), with (n = 7) and without (n = 7) visible fungal
growth, presumed to be Pd, from three hibernacula in
Northern Bavaria, Germany, during March 2012. Bats
were immediately euthanized upon collection and were
not aroused prior to collection of blood samples. Blood
was processed and stored as described above.
Measuring anti-Pd antibody titers
Plasma antibody titers were measured using an enzyme-
linked immunosorbent assay (ELISA) in U-bottom
96-well plates with 100,000 formalin-fixed Pd conidia sus-
pended in 200 lL PBS containing 0.05% Tween-20
(PBST) and 1% bovine serum albumin (PBST+BSA). The
concentration of Pd cells was determined using a hemocy-
tometer. Plates were spun in a centrifuge at 600 g for
5 min, and the supernatant discarded. We then added
50 lL of bat plasma diluted in PBST+BSA at concentra-
tions of 1:100 and 1:1000 to wells and incubated on a
plate shaker for 1 h at 20–24°C. Cells were then washed
twice with PBS before adding 50 lL of biotinylated pro-
tein A/G (BioVision, Inc., Milpitas, CA) diluted in
PBST+BSA at a concentration of 1:10,000 and incubated
on a plate shaker for 1 h at 20–24°C. Cells were then
washed twice with PBS before adding 50 lL streptavidin
peroxidase polymer, ultrasensitive (Sigma-Aldrich, St.
Louis, MO) diluted in PBST+BSA at a concentration of
1:2000 and incubated for 30 min on a plate shaker at 20–
24°C. Cells were then washed three times with PBS before
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incubating with 100 lL tetramethylbenzidine (eBio-
science, San Deigo, CA). The reaction was terminated
after 15 min using 10 lL of 10% trichloroacetic acid.
Absorbance was measured at 450 nm on a microplate
spectrophotometer (BioTek lQuant, Winooski, VT).
Background absorbance was subtracted from all samples
using negative control wells that received PBST+BSA
instead of plasma. Serum from a rabbit immunized and
boosted with lyophilized Pd (LAMPIRE Biological Labo-
ratories, Pipersville, PA) was used for a positive control
and to validate the assay. Samples with absorbance <0.1
units above background (3 standard deviations) were
assigned a titer of 10 and considered not-detectable for
anti-Pd antibodies. For the remaining samples, the bat
was considered to be seropositive and titer was calculated
by multiplying the absorbance by the dilution. The titer
from the sample diluted 1:100 was used unless both 1:100
and 1:1000 titers were above 50, and then, the largest titer
of the two concentrations was assigned. Because samples
were analyzed on different days, positive titers were stan-
dardized across assays using the average absorbance value
of triplicate samples of the rabbit anti-Pd positive control
at a dilution of 1:1000. All plasma samples were measured
on two separate days and produced similar results on
each day after standardization.
Statistical analysis
We used chi-square tests to compare seroprevalence (the
proportion of samples with detectable antibodies against
Pd) between captive little brown myotis cutaneously
inoculated with Pd and sham inoculated with PBS. Bats
testing positive for anti-Pd antibodies at any of the three
time points were considered positive for antibodies for
this comparison. We tested our hypothesis that titers
would peak shortly after hibernation using a longitudinal
nonparametric alternative to a repeated measures analy-
sis, Friedman’s test, because titer data could not be
transformed to meet the assumptions of parametric tests.
We used Wilcoxon rank-sum tests as a method of means
comparisons between time points. We also used Wilco-
xon rank-sum tests to compare antibody titers between
the two groups at each time point to test the hypothesis
that titers would be greatest among little brown myotis
inoculated with Pd. Similarly, we compared seropreva-
lence between little brown myotis immunized with live
Pd and bats sham-injected using chi-square tests and
compared titers between the two groups using a Wilco-
xon rank-sum test.
We used chi-square tests to compare seroprevalence
and Kruskal–Wallis tests to compare antibody titers to
test each of our hypotheses pertaining to wild popula-
tions. When appropriate, means comparisons were made
using a Wilcoxon rank-sum test or 2 9 2 chi-square tests
with a sequential Bonferroni–Holm correction for each
pair of treatments. To test the hypothesis that antibody
seroprevalence and titers would be greatest in populations
with longer histories of WNS, we compared little brown
myotis sampled during spring in Montana (no known
WNS history) to populations in Kentucky (WNS-positive
since 2011), Pennsylvania (WNS-positive since 2008), and
New York (WNS-positive since 2006). Data collected in
Kentucky during the spring seasons of 2013 and 2014
were combined following verification that seroprevalence
and titer did not vary between years (Table S2). We also
compared seasonal differences in titers for species sam-
pled at the same location at different times of year. To
test the hypothesis that European species would exhibit
greater seroprevalence and titer, we compared greater
mouse-eared myotis samples to samples from North
American species also collected during hibernation and
compared Daubenton’s myotis to little brown myotis
populations in New York, our North American sampling
location with the longest history of WNS, also sampled
during spring.
Changes in Pd loads quantified by PCR on free-rang-
ing bats captured in Kentucky between 2013 and 2014
were compared for each species individually using a Wil-
coxon rank-sum test. Kruskal–Wallis tests were used to
compare Pd loads among species captured in Kentucky
and to compare Pd loads on little brown myotis cap-
tured in Kentucky, Pennsylvania, and New York. Because
Pd loads in several species differed between years, com-
parison among species captured in Kentucky was limited
to species captured in 2014, and only little brown myo-
tis captured in 2014 were compared to bats captured in
New York and Pennsylvania. For illustrating compari-
sons across time and between species, data for some lit-
tle brown myotis groups are found in more than one
figure.
Results
To test whether little brown myotis mount an antibody
response to Pd when infected with the fungus, we com-
pared anti-Pd antibody levels in captive bats previously
infected with Pd (n = 44) to uninfected conspecifics
(n = 44). Fifty-seven of 63 (90%) samples from captive
little brown myotis collected from WNS-negative caves
tested positive for anti-Pd antibodies upon arousal from
hibernation. There was no difference in seroprevalence
(v2 = 0.08, df = 1, P = 0.77) or titer (week 2: Z = 0.63,
P = 0.53; week 6: Z = 1.40, P = 0.16; week 10:
Z = 0.05, P = 0.96) between groups cutaneously inocu-
lated with Pd or sham inoculated with PBS. Anti-Pd anti-
body titers differed across weeks among inoculated bats
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(v2 = 15.6, df = 2, P < 0.001; Fig. 1), with titers at week
2 being significantly greater than at week 6 (v2 = 9.8,
df = 2, P = 0.002) and week 10 (v2 = 10.5, df = 2,
P = 0.001). To determine whether injection with Pd could
increase anti-Pd antibody levels, we injected little brown
myotis with live Pd mixed with an adjuvant. Compared
to bats that were injected with PBS, injected bats exhib-
ited significantly greater anti-Pd antibody titers
(Z = 2.3, P = 0.02), but not seroprevalence (v2 = 3.3,
df = 1, P = 0.07) (Fig. 2).
Next, we determined whether different species have
variable anti-Pd antibody levels throughout the year.
Comparing little brown myotis and tri-colored bats sam-
pled during the spring, summer, and winter in Kentucky
(Fig. 3A), we found little brown myotis exhibited greater
seroprevalence (v2 = 18.0, df = 2, P < 0.001, Table S3)
and titers (v2 = 29.5, df = 2, P < 0.001, see Table S3)
during spring than during winter or summer, but no sig-
nificant seasonal differences were detected among tri-col-
ored bats (seroprevalence: v2 = 1.3, df = 2, P = 0.52;
titer: v2 = 1.2, df = 2, P = 0.56). Among three species
sampled during the spring and summer (Fig. 3B), north-
ern myotis exhibited greater seroprevalence (v2 = 8.0,
df = 1, P = 0.005) and titer (Z = 2.5, P = 0.01) during
spring compared to summer, as did Rafinesque’s big-
eared bats (v2 = 4.2, df = 1, P = 0.04; titer: Z = 2.2,
P = 0.03). Big brown bats exhibited greater titers
(Z = 2.4, P = 0.02), but not seroprevalence (v2 = 3.2,
df = 1, P = 0.08) during spring. Pd loads varied among
species sampled in Kentucky in 2014 (v2 = 30.0, df = 4,
P < 0.001), with little brown myotis having the greatest
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Figure 1. Comparison of anti-Pd antibody titers in 44 little brown
myotis (Myotis lucifugus) collected from Pd-negative caves
cutaneously inoculated with Pd and hibernated in captivity for
5 months. Anti-Pd titers were highest shortly after the end of
hibernation and then declined. Data are presented with quartiles,
median (black line), and whiskers that represent 1.5 times the
interquartile range. Titers ≤ 10 are considered negative for Pd reactive
antibodies. Titers differed significantly between weeks not sharing
common letters (P < 0.05).
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Figure 2. Comparison of anti-Pd antibody titers in 26 little brown
myotis (Myotis lucifugus) collected from outside the WNS-affected
region of North America and immunized with Pd emulsified with
adjuvant or PBS (sham). Anti-Pd titers were greater in immunized
bats, as denoted by different letters (P < 0.05). Data are presented as
quartiles, median (black line), and whiskers that represent 1.5 times
the interquartile range. Titers ≤ 10 are considered negative for Pd
reactive antibodies.
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Pd loads (Table S4). Comparing anti-Pd antibodies in
North American species sampled in the same location
(Kentucky) at the same time (spring), seroprevalence
(v2 = 60.8, df = 4, P < 0.001) and titer (v2 = 74.03,
df = 4, P < 0.001) significantly varied, with little brown
myotis exhibiting higher seroprevalence and titer com-
pared to all other species (Table S5). Eastern red bats and
evening bats were not included in comparisons due to
sample size but are reported in Table S1. Antibodies
against Pd were never detected among red bats.
To determine whether anti-Pd titers correlate with
length of exposure of a population to WNS, we mea-
sured anti-Pd antibody levels in four North American
populations of little brown myotis during the spring. Se-
roprevalence (v2 = 40.0, df = 3, P < 0.001) and titer
(v2 = 17.8, df = 3, P < 0.001) significantly varied, with
little brown myotis exhibiting higher titers in New York
than in all states except Pennsylvania (Fig. 4, Table S6).
Among little brown myotis sampled in New York and
Pennsylvania, only one bat had noticeable wing damage,
receiving a Reichard score of 1 (Reichard and Kunz
2009). The extent of Pd infection appeared to increase
among bats in Kentucky between 2013 and 2014. Seven
of 20 (35%) of little brown myotis captured in Ken-
tucky in 2013 had a wing damage score of 1, with the
remaining 65% bats exhibiting no damage, but 61%
(n = 11) of bats sampled at the same location in 2014
had moderate (damage index = 2) or severe damage
(value = 3). Furthermore, the median number of Pd
cells (genomic equivalents) detected by qPCR on little
brown myotis (Z = 4.3, P < 0.001), northern myotis
(Z = 4.3, P < 0.001), big brown bats (Z = 4.9,
P < 0.001), and tri-colored bats (Z = 3.2, P = 0.02)
increased between 2013 and 2014. We also detected
greater Pd loads on little brown myotis captured in
Kentucky during 2014 than in New York or Pennsylva-
nia (Table S7).
To determine whether anti-Pd antibody levels differ
between North American and European species, we com-
pared antibody levels in two species of European bats to
M. lucifugus in Kentucky and New York. Winter seropre-
valence (v2 = 20.2, df = 2, P < 0.001, Table S8) and titers
(v2 = 18.8, df = 2, P < 0.001, Table S8) differed between
North American and European species, with no antibod-
ies against Pd detected among greater mouse-eared myotis
in Germany (Fig. 5, Table S8). We were able to detect
anti-Pd antibodies among Daubenton’s myotis sampled
during the spring in Finland, but titers were significantly
lower (Z = 2.4, P = 0.02) and were less likely to be
seropositive (v2 = 9.8, df = 1, P = 0.002) than little
brown myotis sampled in New York during the same
time period (Fig. 5). Summer samples from Daubenton’s
myotis were not included in analyses due to low sample
size, but are reported in Table S1.
M. lucifugus P. subflavus
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Figure 3. Comparison of anti-Pd antibody titers in five free-ranging bat species sampled in Kentucky, USA. (A) Anti-Pd titers were greater in
little brown myotis (Myotis lucifugus) than in tri-colored bats (Perimyotis subflavus) (P < 0.05) and were greatest during the spring in little
brown myotis. (B) Big brown bats (Eptesicus fuscus), northern long-eared myotis (M. septentrionalis), and Rafinesque’s big-eared bats
(Corynorhinus rafinesquii) had greater anti-Pd titers in spring than in summer, and all had lower titers than little brown bats in the spring
(P < 0.05). Data are presented as quartiles, median (black line), and whiskers that represent 1.5 times the interquartile range. Titers ≤ 10 are
considered negative for Pd reactive antibodies. Within each species, titers differed significantly between seasons not sharing common letters
(P < 0.05).
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Discussion
We present the first evidence of an antibody-mediated
immune response to Pd in bats. Contrary to our predic-
tion, we did not observe greater seroprevalence or titers
of anti-Pd antibodies in European than in North Ameri-
can species, and notably, we did not detect antibodies
against Pd among greater mouse-eared myotis both
infected and uninfected with Pd during hibernation. Simi-
larly, anti-Pd antibody levels in a second European spe-
cies, Daubenton’s myotis, were also found to be lower
than in little brown myotis of North America, although
their Pd exposure status was unknown. Thus, bats in Eur-
ope, which have presumably lived with Pd for thousands
of years, have lower antibody titers than species in North
America that have only recently become exposed. These
data provide strong evidence that an antibody-mediated
immune response is not the mechanism of survival
among European bats infected by Pd. This conclusion is
further supported by our finding that little brown myotis,
a species with WNS mortality rates >90% (Turner et al.
2011), have higher anti-Pd antibody titers than any North
American or European species, while some species with
lower mortality rates had lower titers. Furthermore, anti-
bodies reactive against Pd were identified in little brown
myotis that had never been exposed to the fungus. Were
antibodies involved in defense against Pd, one would
expect that little brown myotis would experience higher
survival rates given the prevalence of antibodies in na€ıve
populations.
Consistent with our predictions, however, populations
of little brown myotis inhabiting New York and Penn-
sylvania, where WNS has been present since 2006 and
2008, respectively, had greater seroprevalence and titers
than na€ıve and more recently exposed populations. Lit-
tle brown myotis in New York and Pennsylvania also
exhibited less severe wing damage and had fewer Pd
cells on their skin compared little brown myotis from
Kentucky, where WNS arrived more recently. The pres-
ence of Pd on the skin of bats in Pennsylvania and
New York, along with the presence of Pd in hibernacu-
la across both states, strongly suggests that these bats
had survived a winter exposed to Pd, yet lacked the
secondary symptoms seen in survivors elsewhere (Rei-
chard and Kunz 2009; present study). This suggests that
these bats belong to remnant populations possessing
behavioral and/or physiological traits that aid in surviv-
ing WNS. Our results from captive little brown myotis
and free-ranging European Myotis species lead us to
hypothesize that antibodies are not the mechanism
behind such survival, but instead that high anti-Pd anti-
body titers in these bats are correlates of survival. It is
also possible that the increased titers observed in north-
eastern populations of little brown myotis reflect greater
exposure by living in areas of endemic Pd exposure,
but this is not consistent with what was observed for
other species in the same hibernacula, or with what
was seen in European Myotis.
The correlation between anti-Pd titer and survival may
be similar to that found in mice exposed to the fungal
pathogen Candida albicans, where antibodies were found
to be predictors of the ability of mice to survive infection
once titers exceed a certain threshold, even though cell-
mediated immune responses were the mechanism of suc-
cessful host defense (Spellberg et al. 2008). Although
monoclonal antibodies have been shown to have protec-
tive roles in immune-defense against fungal pathogens,
evidence that naturally produced antibodies has a protec-
tive effect is lacking (Casadevall and Pirofski 2012a,b;
W€uthrich et al. 2012).
In the case of WNS, the opportunity for antibodies to
play a role in host defense is furthered hampered by the
downregulation in immune function ubiquitously
observed among mammalian hibernators (Bouma et al.
2010a). In rodents, for example, hibernation is associated
with leukopenia (Bouma et al. 2010a,b, 2011), reductions
in complement activity (Maniero 2002), and decreased
antibody production (Burton and Reichman 1999; Bouma
et al. 2013). Despite this reduction, however, hibernating
woodchucks (Marmota monax) produce antibodies during
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Figure 4. Comparison of anti-Pd antibody titers determined for little
brown myotis (Myotis lucifugus) captured in spring across North
America. Anti-Pd titers are lowest, but still detectable, in Montana
(WNS-negative), followed by Kentucky (WNS-positive since 2011),
then Pennsylvania (WNS-positive since 2008), and the highest titers
were found in New York (WNS-positive since 2006). Data are
presented as quartiles, median (black line), and whiskers that
represent 1.5 times the interquartile range. Titers ≤ 10 are considered
negative for Pd reactive antibodies. Titers differed significantly
between locations not sharing common letters (P < 0.05).
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hibernation, even when primary exposure occurs during
hibernation (Beaudoin et al. 1969), and no decline in
antibody responses to a T-cell-dependent antigen was
observed in a study of hibernating 13-lined ground squir-
rels (Ictidomys tridecemlineatus) (Bouma et al. 2013). Sim-
ilarly, we observed that little brown myotis have
detectable levels of anti-Pd antibodies during winter, and
in some cases exhibited relatively high titers.
Our results from free-ranging little brown myotis sam-
pled in the winter and spring, and bats exposed to Pd in
captivity, suggest that anti-Pd antibody levels peak shortly
after emergence from hibernation. Thus, circulating anti-
bodies against Pd in little brown myotis peak after bats
have left their hibernacula, outside of which the fungus is
unable to grow due to temperature restrictions on Pd
growth (Verant et al. 2012). Other studies of WNS-
affected bats suggest both the presence (Meteyer et al.
2012; Moore et al. 2013) and absence (Meteyer et al.
2009) of an inflammatory immune response to Pd during
winter (see also the discussion in Brook and Dobson
2015). Although our results suggest that much of the
immune response to Pd occurs in spring, consistent with
the work of Meteyer et al. (2012), it is critical to note
that we sampled visibly sick bats during winter, suggest-
ing these bats were unlikely to survive. Thus, studies of
little brown myotis populations surviving with WNS are
needed to better assess circulating antibody during winter.
It is notable that several little brown myotis popula-
tions far outside the WNS-affected zone tested positive
for anti-Pd antibodies. Little brown myotis must, there-
fore, produce antibodies that are cross-reactive with Pd
and other pathogens. Cross-reactivity of antibodies to
various fungal pathogens is not uncommon, with anti-
body binding often occurring at common molecular sur-
face patterns shared across many species (Rappleye et al.
2007). Thus, antibodies that recognize these surface mole-
cules – a common pattern recognized by antifungal anti-
bodies (W€uthrich et al. 2012) – will recognize Pd. A great
number of fungal species are present in bat hibernacula
(Lorch et al. 2013), serving as possible sources of primary
exposure to molecular patterns to which antibodies can
be produced.
Not all species produced antibodies against Pd, how-
ever, and anti-Pd antibody titers varied significantly
among species. These differences among species may be
linked to differences in winter ecology or physiology. We
predicted that big brown bats and Rafinesque’s big-eared
bats would exhibit higher antibody titers because these
species have relatively low WNS mortality rates (Turner
et al. 2011), arouse more frequently from hibernation
(Brack and Twente 1985; Twente et al. 1985; Johnson
et al. 2012), and because immune function (at least in
rodents) is known to be rapidly restored during periodic
arousals (Maniero 2002; Bouma et al. 2011). Contrary to
this prediction, however, these species exhibited lower
seroprevalence and titers than the smaller little brown
myotis. Another small species with infrequent arousals
and high WNS mortality, tri-colored bats (Brack and
Twente 1985; Twente et al. 1985; Turner et al. 2011),
had the lowest titers and seroprevalence of any North
American species. Thus, no consistent relationship was
observed between antibody titer and body size or winter
arousal frequency. Differences in WNS susceptibility
across North American species cannot be explained
by differences in ability to mount a humoral immune
response.
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Figure 5. Comparison of anti-Pd antibody
titers in free-ranging bat species in North
America and Europe. (A) Anti-Pd titers were
greater in little brown myotis (Myotis lucifugus)
in New York, USA, than in Daubenton’s myotis
(M. daubentonii) in Finland during spring.
(B) Anti-Pd titers were greater in little brown
myotis hibernating in Kentucky, USA, than in
Daubenton’s myotis hibernating in Germany.
Data are presented as quartiles, median (black
line), and whiskers that represent 1.5 times the
interquartile range. Titers ≤ 10 are considered
negative for Pd reactive antibodies. Titers
differed significantly between species not
sharing common letters within each panel
(P < 0.05).
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Antifungal immune responses are not always protective
and antibodies, in particular, can be associated with
immune pathology instead of protection. Protection
depends on the type of T cells activated and cytokines pro-
duced. For example, immune responses dominated by the
Th2 phenotype are frequently characterized as permissive
or exacerbating the effects of fungal disease (Cenci et al.
1997; Jain et al. 2009; Haraguchi et al. 2010) while Th17
cells generally promote protection from fungal infection
(Conti et al. 2009; Hernandez-Santos and Gaffen 2012).
Unlike the role of antifungal antibodies in defense, cell-
mediated immune responses have well-known roles in
clearing fungal infections in mammals (Spellberg et al.
2008; Hernandez-Santos and Gaffen 2012). Given that we
were unable to detect antibodies against Pd in greater
mouse-eared myotis infected with Pd during winter, and
Pd is associated with pathology but not mortality in this
species (Pikula et al. 2012), we hypothesize that cell-medi-
ated immune responses aid in host defense in this species.
Furthermore, we hypothesize that cell-mediated immune
responses are also involved in host defense in North Amer-
ican species with relatively low WNS mortality rates, such
as big brown bats and Rafinesque’s big-eared bats (Frank
et al. 2014). In our study, these species exhibited signifi-
cantly lower seroprevalence and titers of anti-Pd compared
to little brown myotis in Kentucky, despite presence of Pd
on the skin of all species. Although Pd was present and
anti-Pd antibody titers were low in big brown bats and
Rafinesque’s big-eared bats, we observed no wing damage
among individuals of these species in Kentucky.
This study provides strong evidence that antibody-
mediated immunity is not the mechanism behind survival
of European or North American bats infected with Pd.
Thus, our finding that anti-Pd antibody titers can be
increased in little brown myotis through vaccination must
be considered in the context of this role of antibody-med-
iated immunity. In mice, immunization against fungal
pathogens shows that immunization can confer protection
if cell-mediated immune responses are the result of vacci-
nation and that protection was also associated with
high antibody titers (Spellberg et al. 2008). Thus,
although antibody-mediated immune responses are not a
mechanism for promoting survival of WNS, immunizing
bats may still confer protection against Pd if cell-mediated
immune responses also result.
In conclusion, our study on circulating antibodies
against the fungus that causes WNS provides evidence
that an antibody-mediated immune response is insuffi-
cient to explain survival of North American or European
bats infected with Pd. Although antibodies against Pd are
correlates of protection for little brown myotis, their pres-
ence cannot explain the survival of remnant populations
of little brown myotis in the northeastern United States
(as documented by Dobony et al. 2011 and Reichard
et al. 2014). The low Pd loads and absence of secondary
injuries (Reichard and Kunz 2009; Meteyer et al. 2012)
we observed among little brown myotis in remnant popu-
lations of survivors in New York and Pennsylvania sug-
gest that these populations are physiologically different
from populations in Kentucky, where Pd has more
recently been introduced. These results provide hope that
little brown myotis are adapting to life with WNS.
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